Skip to main content

UPDATE 1-Aimmune sees slowdown in launch of peanut allergy therapy due to coronavirus

Aimmune Therapeutics Inc said on Monday the launch of its peanut allergy therapy may be slowed by the spread of coronavirus in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.